<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医麦客 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-23T11:10:05+08:00</updated>
  <subtitle>医麦客是一个聚焦转化医学、精准医疗和生物制药的专业媒体平台，持续关注体外诊断、抗体药物、细胞治疗、基因治疗等细分领域。为新生物医药医疗领域的企业发声，推动企业和行业的快速发展。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>CBioPC 2020重磅亮相丨生物制药领域热门细分赛道，赛默飞整体解决方案全面覆盖</title>
    <updated>2020-11-23T09:21:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/_drxtXXFaxmI4-g_H6A0Lg</id>
    <link href="https://mp.weixin.qq.com/s/_drxtXXFaxmI4-g_H6A0Lg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>大国博弈下生物医药行业的破局之法-峰客独家访谈Mann Fung博士</title>
    <updated>2020-11-23T09:21:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/kkDxoCib6sqqpVgNMNySIg</id>
    <link href="https://mp.weixin.qq.com/s/kkDxoCib6sqqpVgNMNySIg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>诺奖得主创办的公司达成最新合作，进一步推进异体CD371 CAR-T研究丨医麦猛爆料</title>
    <updated>2020-11-23T09:21:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/3RGSOpRZQPvEnr9AoZiKcw</id>
    <link href="https://mp.weixin.qq.com/s/3RGSOpRZQPvEnr9AoZiKcw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>倒计时1天！2020精准医学产业化(上海)高峰论坛即将在上海开幕</title>
    <updated>2020-11-23T09:21:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/lD2IBPwpMWwjS0GtG0zoWw</id>
    <link href="https://mp.weixin.qq.com/s/lD2IBPwpMWwjS0GtG0zoWw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>慢病毒造血干细胞基因疗法获美国FDA批准临床，在欧洲即将进入商业化阶段丨医麦猛爆料</title>
    <updated>2020-11-23T09:21:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/P0cTF-DZ3As15uz7wvNVnA</id>
    <link href="https://mp.weixin.qq.com/s/P0cTF-DZ3As15uz7wvNVnA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>非小细胞肺癌免疫治疗新突破，显著延长患者无进展生存期，降低疾病进展或死亡风险50%！丨医麦猛爆料</title>
    <updated>2020-11-22T17:05:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/C8C4_4yEpjiu4UdCt9AbBA</id>
    <link href="https://mp.weixin.qq.com/s/C8C4_4yEpjiu4UdCt9AbBA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>东曜药业亮相ESMO ASIA，首次公布贝伐珠单抗注射液III期研究结果丨医麦猛爆料</title>
    <updated>2020-11-22T17:05:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/bTRRwtVrgxlsskZ__d7qMA</id>
    <link href="https://mp.weixin.qq.com/s/bTRRwtVrgxlsskZ__d7qMA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>IL-15装甲的可控TIL疗法即将启动！更强的抗肿瘤活性和安全性丨医麦猛爆料</title>
    <updated>2020-11-22T17:05:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/qzqFT4DumHCkbDEgGKzWWA</id>
    <link href="https://mp.weixin.qq.com/s/qzqFT4DumHCkbDEgGKzWWA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>陈方平教授：基因治疗遗传性血液病疗效令人振奋，未来进入临床应用可期可待</title>
    <updated>2020-11-22T17:05:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/FoNf1olGvzgjNaMNesF4kw</id>
    <link href="https://mp.weixin.qq.com/s/FoNf1olGvzgjNaMNesF4kw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药融资丨生物技术领域投资市场巨大，千万级投资已是平常</title>
    <updated>2020-11-22T17:05:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/XhCC_BV6QKpH41M2LnIAvA</id>
    <link href="https://mp.weixin.qq.com/s/XhCC_BV6QKpH41M2LnIAvA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>在体改造CAR-T细胞大幅降低成本！新贵生物技术公司完成5300万美元A轮融资丨医麦黑科技</title>
    <updated>2020-11-20T23:31:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/6IFuiW7IjpSoxLSXzeAITg</id>
    <link href="https://mp.weixin.qq.com/s/6IFuiW7IjpSoxLSXzeAITg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第三款RNAi药物上市！Alnylam坐拥RNAi领域江山丨医麦猛爆料</title>
    <updated>2020-11-20T23:31:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/b3Y-VIv23OzFoTXG4MRnRw</id>
    <link href="https://mp.weixin.qq.com/s/b3Y-VIv23OzFoTXG4MRnRw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>​马军教授：免疫靶向治疗方兴未艾，联合治疗是未来发展方向</title>
    <updated>2020-11-20T23:31:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/KYWtcNl6Zrp6myntHV9zbg</id>
    <link href="https://mp.weixin.qq.com/s/KYWtcNl6Zrp6myntHV9zbg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>「峰客访谈」君赛生物创始人金华君博士：TIL将成为晚期实体肿瘤非常有前景的治疗方向</title>
    <updated>2020-11-20T23:31:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/wsNVuuwu2ndxcHIk2jwflg</id>
    <link href="https://mp.weixin.qq.com/s/wsNVuuwu2ndxcHIk2jwflg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>快速发展的生物制药领域驱动CDMO产能不断扩大，如何全面评估最适合您需求的CDMO合作伙伴？丨星耀研究院</title>
    <updated>2020-11-20T09:19:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/tFbAHiYX5Hh9pXCUSIP1Gg</id>
    <link href="https://mp.weixin.qq.com/s/tFbAHiYX5Hh9pXCUSIP1Gg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球首推全长Claudin18.2蛋白——抗体药质量放行篇​</title>
    <updated>2020-11-20T09:19:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/BLGZA1kzXknCqCsiI-JO7Q</id>
    <link href="https://mp.weixin.qq.com/s/BLGZA1kzXknCqCsiI-JO7Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>mRNA疫苗研发火热进行，行业如何把控安全性及免疫效力评价的关键环节丨医麦课堂</title>
    <updated>2020-11-20T09:19:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/SzVtgSrjv2Dtm5i5Yh4IGg</id>
    <link href="https://mp.weixin.qq.com/s/SzVtgSrjv2Dtm5i5Yh4IGg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>95%超高有效率！复星新冠疫苗国内如何桥接加快上市？丨医麦新观察</title>
    <updated>2020-11-20T09:19:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/psPpUNMlUirm3pDbVL4BZQ</id>
    <link href="https://mp.weixin.qq.com/s/psPpUNMlUirm3pDbVL4BZQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>溶瘤病毒新种类，更优的安全性实现静脉给药丨医麦猛爆料</title>
    <updated>2020-11-20T09:19:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/4UddUeVJSPOn8SKYGUziUw</id>
    <link href="https://mp.weixin.qq.com/s/4UddUeVJSPOn8SKYGUziUw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>王建祥教授：CAR-NK细胞疗法—治疗血液肿瘤的又一利器</title>
    <updated>2020-11-20T09:19:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/2f8GVFLs9ap7kV9vPznd8Q</id>
    <link href="https://mp.weixin.qq.com/s/2f8GVFLs9ap7kV9vPznd8Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>